Fibrinogen. Proceedings/ Workshop on Fibrinogen. / Vol. 3, : Structural variants and interactions ; Stockholm, Sweden, July 9–10, 1983 / / hrsg. von A. Henschen.
Saved in:
Table of Contents:
- Frontmatter
- Preface
- Contents
- I. A HISTORICAL NOTE
- Two thousand years of fibrinogen research and evidence for fibrin being the first protein
- II. GENE ANALYSIS
- Fibrinogen evolution - The structure and evolution of fibrinogen: The coiled coil region
- Absence of gross defect of fibrinogen genes in one patient with congenital afibrinogenemia
- III. FIBRINOGEN-FIBRIN CONVERSION
- Fibrinogen to fibrin - an overview
- Fibrin - specific monoclonal antibodies are elicited by immunization with a synthetic fibrin-like peptide
- Enhancement of fibrin polymerization by active site - inhibited thrombin
- Peptides released from human fibrinogen by thrombic enzymes
- The analysis of fibrinopeptide release from S--carboxymethylated fibrinogen chains using high-performance liquid chromatography
- Moaification of the fibrin a-chain by dipeptidyl peptidase IV
- IV. FIBRINOGEN-FIBRIN INTERACTION
- Analysis of composition of soluble fibrinogen/fibrin complexes by differential ultracentrifugation
- Reversible interactions of fibrin and fibrinogen: an ultracentrifugation study
- V. NORMAL FIBRINOGEN VARIANTS
- Evidence that the amount of heparin precipitable fraction is influenced by fibrinogen quality
- The location of a second in vivo phosphorylation site in the Aa-chain of human fibrinogen
- Evidence that the y chain population of human platelet fibrinogen lacks the y' variant that is present in plasma fibrinogen
- Differences and similarities between human adult and fetal fibrinogen fragments D1
- VI. ABNORMAL FIBRINOGEN VARIANTS
- Functional defects in abnormal fibrinogens
- Study of 10 cases of congenital dysfibrinogenemia: clinical and molecular biological aspects
- Fibrinogens Sydney I and II, a kinetic study of (His16 )FPA cleavage and its effect on FPB cleavage
- Fibrinogens London I - IV, Manchester, Sydney I and II. Cleavage of fibrinopeptides by thrombin and expression of their polymerisation abnormalities
- Aspects of evaluation of fibrinogen Stony Brook - A defect resulting in failure to release fibrinopeptide A
- Fibrinogen Tokyo II: An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules
- Fibrinogen Milan II: A congenital dysfibrinogenemia with a defective clotting by thrombin, normal clotting by arvin, reptilase and prothrombin-staphy1ocoagulase complex, associated with thrombotic episodes
- Preliminary report concerning two new cases of congenital dysfibrinogenemia (Homburg II and Homburg III)
- The effect of sodium citrate on fibrin polymerisation in patients with liver disease
- VII. FIBRINOGEN DEGRADATION PRODUCTS
- Studies of the proteolytic fragments of the C-terminal portion of the a-chain of human fibrinogen
- Biodistribution or human fibrinogen-derived peptides in rabbits
- Structure-function studies on a vasoactive pentapeptide derived from plasm in degradation of human fibrin(ogen)
- Purification and characteristics of a vasoactive peptide derived from elastase degradation of human fibrin(ogen)
- Relation of crosslinked to non crosslinked fibrin derivatives in tumor ascites compared to cirrhosis ascites
- VIII. INTERACTION WITH PLASMINOGEN AND ITS ACTIVATOR
- Study of the interaction between plasminogen and fibrinogen degradation products using immunoenzymological assay
- Fibrin and plasminogen structures involved in the tissue-type plasminogen activator catalyzed activation of plasminogen
- Kinetics of the tissue-type plasminogen activatormediated activation of plasminogen. Influence of CNBr fibrin(ogen) fragment FCB-2 and different forms of plasminogen
- IX. INTERACTION WITH CELLS
- Structural characterization of the recognition site for platelet receptors on human fibrinogen
- Binding or fibrinogen to ADP-treated platelets: Importance of the Aα-chain
- Inhibition of fibrinogen binding to activated platelets by oligoamines
- Specific interaction between fibrinogen-fibrin and endothelial cells
- Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells
- Interaction of fibrin with malignant melanoma cells in long term culture
- AUTHOR INDEX
- SUBJECT INDEX
- Backmatter
Similar Items
-
Fibrinogen. Proceedings/ Workshop on Fibrinogen. / [1], : Recent biochemical and medical aspects ; International Symposium, February 17-18, 1981, Max-Planck-Institute for Biochemistry, Martinsried/Munich, Germany / / A. Henschen, H. Graeff, F. Lottspeich.
Published: ([2019]) -
Fibrinogen. Proceedings/ Workshop on Fibrinogen. / Vol. 4, : Fibrin formation and Fibrinolysis ; April, 2–3, 1985, London, England / / hrsg. von D. A. Lane.
Published: ([2019]) -
Fibrinogen. Proceedings/ Workshop on Fibrinogen. / [2], : Structure, functional aspects, metabolism ; May 12-14, 1982, Leiden, The Netherlands / / F. Haverkate, A. Henschen.
Published: ([2019]) -
CTE workshop proceedings.
Published: (2013-) -
Survey automation : report and workshop proceedings / / Daniel L. Cork (Oversight Committee for the Workshop on Survey Automation) ... [et al.], editors. ; Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Research Council.
Published: (c2003.)